首页> 外文期刊>Chinese Journal of Integrated Traditional and Western Medicine >Clinical Study on Early Senile Cataract Treated by Shezhu Mingmu Powder
【24h】

Clinical Study on Early Senile Cataract Treated by Shezhu Mingmu Powder

机译:蛇zhu明目散治疗老年性白内障的临床研究

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To evaluate the clinical effect of Shezhu Mingmu powder (SZMMP) in treatment of early senile cataract. Methods: A comparison was made between the treatment group, 162 eyes of 92 cases of early senile cataract treated by SZMMP, and the control group, 57 eyes of 30 cases treated by drops baineitini. The treatment periods were one to three months. Results: The total effective rate for the treatment group was 79.01 % and the rate of obvious improvement was 25.31 % . In the treatment group both rateswere clearly higher than the rates (36.84% and 7.02%) of the control group. After 4 to 8 months' following up, treatment of 42 cases showed that most of them reached the best curative effect within 1 to 3 months. Conclusion: SZMMP is obviously effective in improving visual acuity of early senile cataract, but the lens opacity was not changed.
机译:目的:探讨蛇zhu明目散(SZMMP)治疗老年性白内障的临床疗效。方法:比较治疗组92例SZMMP治疗老年性白内障162眼和对照组30例白内障滴眼剂57眼。治疗期为一到三个月。结果:治疗组总有效率为79.01%,明显改善率为25.31%。在治疗组中,这两个比率均明显高于对照组(分别为36.84%和7.02%)。随访4〜8个月,治疗42例,多数在1〜3个月内达到最佳疗效。结论:SZMMP对改善老年性白内障的视力有明显效果,但晶状体混浊度没有改变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号